Palisade Capital Management

ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company's treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson's disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington's disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.

Mitralign is a venture backed privately held company located in a suburb of Boston, MA. The company is developing an innovative catheter based technology for percutaneous treatment of functional mitral regurgitation. The novel Mitralign system emulates surgical annuloplasty as it delivers a series of surgical implants directly into the mitral annulus by means of a catheter. The implants are cinched together, thus reducing the size of the mitral valve annulus and the valve opening. Mitralign is funded by top tier venture capitalists and has two major cardiovascular device companies as investors.

Ikonisys, Inc. specializes in designing and manufacturing medical diagnostic products aimed at cancer diagnosis and genetic disorder detection in the United States and Europe. The company offers a range of innovative products, including the Ikoniscope Robotic Microscope, which automates slide handling, scanning, and real-time image analysis to minimize human error in testing. Key applications include oncoFISH bladder for analyzing urine samples, oncoFISH her2 for assessing HER2 status in breast tissue, and oncoFISH PTEN for detecting PTEN gene deletions in prostate biopsies. Additionally, Ikonisys provides FISH scanning applications for both cell suspensions and various tissue sections, along with the IkoniWAN Gateway, a remote access solution for digital microscopy systems. Founded in 1999 and headquartered in New Haven, Connecticut, Ikonisys is committed to advancing diagnostic medicine through early and non-invasive disease detection, thereby enhancing patient management.

Language Weaver, Inc. specializes in developing and licensing automated translation solutions tailored for multinationals, government organizations, and translation providers. The company offers a range of products, including the LW Enterprise Translation Server, an on-site software designed for language translation within enterprises. Additionally, it provides the LW Custom Enterprise Translation Server, which focuses on domain-specific translations across various industries such as information technology, automotive, medical, and finance. For immediate translation needs, Language Weaver offers LW Translation On Demand, along with a dedicated server option through LW Custom Translation On Demand. The company also provides professional services, including software training, custom language pair development, and the preparation of parallel data, ensuring comprehensive support for its clients' translation requirements.

Achieve3000 delivers differentiated literacy solutions proven to increase reading comprehension and fluency, vocabulary and writing proficiency for students in grades 2 through 12. Through its proprietary software engine, the company uses the Internet to provide each student with an appropriate version of the same content based on his or her reading level. The company's products include KidBiz3000 (a reading and writing program for grades 2 through 5), TeenBiz3000 (a reading and writing program for grades 6 through 12) and Spark3000® (a reading and writing program for adult learners).